A Phase I Study of Systemic Gene Therapy With SGT-94 in Patients With Solid Tumors (SGT94-01)

This study is currently recruiting participants.
Verified October 2013 by SynerGene Therapeutics, Inc.
Sponsor:
Information provided by (Responsible Party):
SynerGene Therapeutics, Inc.
ClinicalTrials.gov Identifier:
NCT01517464
First received: January 17, 2012
Last updated: October 7, 2013
Last verified: October 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: January 2014
  Estimated Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)